ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3156

Adding MRI of the Spine to the ASAS Classification Criteria for Axial Spondyloarthritis, Redundant or Beneficial? Results from the Spondyloarthritis Caught Early (SPACE)-Cohort

Zineb Ez-Zaitouni1, Pauline Bakker1, Miranda van Lunteren1, Rosaline van den Berg2, M. Reijnierse3, Karen M Fagerli4, Roberta Ramonda5, Robert Landewé6, Lennart T.H. Jacobsson7, Floris van Gaalen1 and Désirée van der Heijde1, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Radiology, Leiden University Medical Center, Leiden, Netherlands, 4Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 5Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Italy, 6Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center, Amsterdam, Netherlands, 7Department of Rheumatology and Inflammation Research, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Imaging and spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, November 16, 2016

Title: Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment V: Imaging of Spondyloarthritis

Session Type: ACR Concurrent Abstract Session

Session Time: 9:00AM-10:30AM

Background/Purpose: The ASAS definition of a positive MRI is solely based on inflammation in the sacroiliac joints (SI), although spinal inflammatory lesions on MRI suggestive of axial Spondyloarthritis (axSpA) may also occur. It is not well established yet how often inflammation in the spine is present in absence of inflammation in the SI and consequently if it is useful to change the definition of a positive MRI to include inflammation in the spine. The aim is to analyze the prevalence of spinal inflammation on MRI in patients with chronic back pain at baseline, and to evaluate the yield of adding MRI-spine as imaging criterion in the ASAS classification criteria for axSpA.

Methods: The SPACE-cohort includes patients with chronic back pain (≥3 months, ≤2 years, onset <45 years) in six participating Rheumatology centers. All available baseline radiographs (X-SI), MRI of SI (MRI-SI) and spine (MRI-spine) were independently scored by 3 well-calibrated readers for each method. MRI-SI was scored according to the ASAS definition. Bone marrow edema suggestive of axSpA was assessed in the entire spine and only counted if visible on ≥2 consecutive slices. For the definition of a positive MRI-spine two cut-off values for inflammatory lesions were used: ≥3 inflammatory lesions (ASAS consensus definition) and ≥5 inflammatory lesions (defined as the optimal cut-off value). All modalities were considered positive if 2/3 readers agreed.

Results: All patients with X-SI, MRI-spine, and MRI-SI available at baseline (n=487) were included in the analysis. Of the 487 patients, 73 (15.0%) patients had a positive MRI-SI, of which 23/73 (31.5%) patients had a positive MRI-spine (≥3 inflammatory lesions) and 17/73 (11.4%) patients had a positive MRI-spine defined by ≥5 inflammatory lesions. In total, 50/414 (12.1%) and 18/414 (4.3%) patients with negative MRI-SI had a positive MRI-spine according to ≥3 and ≥5 inflammatory lesions, respectively. Addition of MRI-spine to the classification criteria by ≥5 inflammatory lesions would lead to classification of 16 additional patients via the imaging arm, with 8 patients already fulfilling the clinical arm. The newly classified patients (n=8) had a mean number (SD) of SpA-features of 1.5 (1.1) of whom 3/8 (37.5%) were HLA-B27 positive. Furthermore, one patient had inflammatory bowel disease and two patients were positive for peripheral arthritis. Most reported SpA-features were inflammatory back pain, good response to NSAIDs, and positive family history for SpA.

Conclusion: In this cohort, a positive MRI-spine in the absence of sacroiliitis on MRI was rarely seen. Addition of MRI-spine as an imaging criterion to the ASAS axSpA criteria had a low yield in number of classifications, and included mostly patients with a low probability of having axSpA. Therefore, performing MRI of the spine is of little value in the classification of patients with short duration CBP and suspicion of axSpA.


Disclosure: Z. Ez-Zaitouni, None; P. Bakker, None; M. van Lunteren, None; R. van den Berg, None; M. Reijnierse, None; K. M. Fagerli, None; R. Ramonda, None; R. Landewé, None; L. T. H. Jacobsson, None; F. van Gaalen, None; D. van der Heijde, None.

To cite this abstract in AMA style:

Ez-Zaitouni Z, Bakker P, van Lunteren M, van den Berg R, Reijnierse M, Fagerli KM, Ramonda R, Landewé R, Jacobsson LTH, van Gaalen F, van der Heijde D. Adding MRI of the Spine to the ASAS Classification Criteria for Axial Spondyloarthritis, Redundant or Beneficial? Results from the Spondyloarthritis Caught Early (SPACE)-Cohort [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/adding-mri-of-the-spine-to-the-asas-classification-criteria-for-axial-spondyloarthritis-redundant-or-beneficial-results-from-the-spondyloarthritis-caught-early-space-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/adding-mri-of-the-spine-to-the-asas-classification-criteria-for-axial-spondyloarthritis-redundant-or-beneficial-results-from-the-spondyloarthritis-caught-early-space-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology